tolazamide has been researched along with glyburide in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (48.15) | 18.7374 |
| 1990's | 4 (14.81) | 18.2507 |
| 2000's | 4 (14.81) | 29.6817 |
| 2010's | 5 (18.52) | 24.3611 |
| 2020's | 1 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Barton, P; Luker, T; Wenlock, MC | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Hoder, A; Losert, W; Scholz, C | 1 |
| Bullock, I; Galloway, DB; Gilbert, JC; Petrie, JC; Watson, WA | 1 |
| Friedberg, SJ; Pugh, JA; Ramirez, G; Sawyer, J; Tuley, M; Wagner, ML | 1 |
| Blas, SD; Davis, FB; Davis, PJ; Mylotte, KM; Warnick, PR | 1 |
| Efendić, S; Grill, V; Gutniak, M; Nylén, A; Ostenson, CG | 1 |
| Boyd, AE; Gaines, KL; Hamilton, S | 1 |
| Gavin, JR | 1 |
| Brown, KF; Crooks, MJ | 1 |
| Stowers, JM | 1 |
| de Baere, H; de Leeuw, I; Decraene, P; Lemmens, P; Verhaegen, H | 1 |
| Howanitz, J; Miller, M; Moses, AM | 1 |
| Lockwood, DH; Maloff, BL; McCaleb, ML; Nowak, SM | 1 |
| Feldman, JM; Skillman, TG | 1 |
| Salzman, AL; Szabó, C | 1 |
| Selvaag, E | 1 |
| Delaey, C; Van de Voorde, J | 1 |
| Brioni, JD; Gopalakrishnan, M; Molinari, EJ; Monteggia, LM; Roch, JM; Scott, VE; Shieh, CC; Sullivan, JP; Whiteaker, KL | 1 |
| Jannetto, PJ; Langman, LJ | 1 |
3 review(s) available for tolazamide and glyburide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis.
Topics: Blood Glucose; C-Peptide; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; MEDLINE; Meta-Analysis as Topic; Middle Aged; Periodicals as Topic; Sulfonylurea Compounds; Tolazamide; Treatment Outcome; United States | 1992 |
Oral treatment in diabetes.
Topics: Acetohexamide; Acidosis; Administration, Oral; Animals; Biguanides; Cardiovascular Diseases; Chlorpropamide; Diabetes Complications; Diabetes Mellitus; Glyburide; Humans; Hypoglycemia; Liver; Obesity; Structure-Activity Relationship; Sulfonylurea Compounds; Tolazamide; Tolbutamide | 1972 |
1 trial(s) available for tolazamide and glyburide
| Article | Year |
|---|---|
Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis.
Topics: Blood Glucose; C-Peptide; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; MEDLINE; Meta-Analysis as Topic; Middle Aged; Periodicals as Topic; Sulfonylurea Compounds; Tolazamide; Treatment Outcome; United States | 1992 |
24 other study(ies) available for tolazamide and glyburide
| Article | Year |
|---|---|
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Lipophilicity of acidic compounds: impact of ion pair partitioning on drug design.
Topics: Acids; Albumins; Drug Design; Humans; Hydrogen-Ion Concentration; Lipids; Molecular Structure; Pharmaceutical Preparations; Protein Binding | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
[Experimental studies on the mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 2. Modification of blood sugar and thrombocyte aggregation by oral antidiabetics].
Topics: Adenosine Monophosphate; Administration, Oral; Animals; Biguanides; Blood Glucose; Carbutamide; Depression, Chemical; Dose-Response Relationship, Drug; Glyburide; Hypoglycemic Agents; Injections, Intravenous; Platelet Adhesiveness; Platelet Aggregation; Pyrimidines; Rats; Semicarbazides; Sulfonylurea Compounds; Tolazamide; Tolbutamide | 1975 |
In vivo cytogenetic activity of sulphonylurea drugs in man.
Topics: Adult; Chlorpropamide; Chromosome Aberrations; Chromosome Deletion; Diabetes Mellitus; Female; Glyburide; Humans; Lymphocytes; Male; Middle Aged; Pregnancy; Sulfonylurea Compounds; Tolazamide; Translocation, Genetic | 1976 |
Differential activities of tolbutamide, tolazamide, and glyburide in vitro on rabbit myocardial membrane Ca2+-transporting ATPase activity.
Topics: Animals; Calcium; Calcium-Transporting ATPases; Calmodulin; Cell Membrane; Female; Glyburide; Heart; In Vitro Techniques; Male; Milrinone; Myocardium; Pyridones; Rabbits; Thyroxine; Tolazamide; Tolbutamide | 1986 |
Sulfonylurea-induced inhibition of glucagon secretion from the perfused rat pancreas: evidence for a direct, non-paracrine effect.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glucagon; Glyburide; In Vitro Techniques; Male; Pancreas; Perfusion; Rats; Rats, Inbred Strains; Sulfonylurea Compounds; Tolazamide | 1986 |
Characterization of the sulfonylurea receptor on beta cell membranes.
Topics: Animals; ATP-Binding Cassette Transporters; Cell Line; Cell Membrane; Cricetinae; Glipizide; Glyburide; Insulin; Islets of Langerhans; Kinetics; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sulfonylurea Compounds; Sulfonylurea Receptors; Temperature; Tolazamide; Tolbutamide | 1988 |
Dual actions of sulfonylureas and glyburide. Receptor and post-receptor effects.
Topics: Adipose Tissue; Animals; Cells, Cultured; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fibroblasts; Glyburide; Humans; Insulin; Insulin Resistance; Mice; Muscles; Obesity; Rats; Receptor, Insulin; Sulfonylurea Compounds; Tolazamide | 1985 |
The binding of sulphonylureas to serum albumin.
Topics: Animals; Carbon Radioisotopes; Cattle; Chlorpropamide; Glyburide; Humans; Hydrogen-Ion Concentration; Protein Binding; Serum Albumin; Serum Albumin, Bovine; Sulfonylurea Compounds; Tolazamide; Tolbutamide | 1974 |
[Hypoglycemia caused by oral antidiabetic agents].
Topics: Adult; Aged; Chlorpropamide; Delayed-Action Preparations; Diet; Female; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Kidney Diseases; Liver Diseases; Male; Middle Aged; Phenformin; Tolazamide; Tolbutamide | 1973 |
Diabetes mellitus: the thin maturity-onset diabetic.
Topics: Acetohexamide; Body Weight; Chlorpropamide; Diabetes Mellitus; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Tolazamide; Tolbutamide | 1972 |
Diuretic action of three sulfonylurea drugs.
Topics: 11-Hydroxycorticosteroids; Acetohexamide; Adrenal Glands; Adult; Autoanalysis; Blood Glucose; Chlorpropamide; Creatinine; Diuresis; Evaluation Studies as Topic; Glyburide; Humans; Male; Natriuresis; Photometry; Potassium; Radioimmunoassay; Tolazamide; Vasopressins; Water | 1973 |
Extrapancreatic effects of sulfonylureas. Potentiation of insulin action through post-binding mechanisms.
Topics: Adipose Tissue; Animals; Biological Transport; Glucose; Glyburide; In Vitro Techniques; Insulin; Male; Rats; Rats, Inbred Strains; Receptor, Insulin; Tolazamide | 1983 |
The pharmacology of sulfonylureas.
Topics: Acetohexamide; Blood Glucose; Chlorpropamide; Diabetes Mellitus; Glyburide; Humans; Insulin; Sulfonylurea Compounds; Tolazamide; Tolbutamide | 1981 |
Inhibition of ATP-activated potassium channels exerts pressor effects and improves survival in a rat model of severe hemorrhagic shock.
Topics: Animals; ATP-Binding Cassette Transporters; Blood Pressure; Disease Models, Animal; Glyburide; Heart Rate; Heparin; KATP Channels; Male; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Rats, Wistar; Shock, Hemorrhagic; Tolazamide | 1996 |
Photohemolytic potency of oral antidiabetic drugs in vitro: effects of antioxidants and a nitrogen atmosphere.
Topics: Antioxidants; Ascorbic Acid; Carbutamide; Chlorpropamide; Dose-Response Relationship, Drug; Gliclazide; Glipizide; Glyburide; Hemolysis; Humans; Hypoglycemic Agents; Nitrogen; Radiation-Sensitizing Agents; Reactive Oxygen Species; Sulfonamides; Sulfonylurea Compounds; Superoxide Dismutase; Tolazamide; Tolbutamide; Ultraviolet Rays; Vitamin E | 1996 |
Heterogeneity of the inhibitory influence of sulfonylureas on prostanoid-induced smooth muscle contraction.
Topics: Animals; Aorta, Thoracic; Arteries; Bronchi; Cattle; Drug Interactions; Female; Gliclazide; Glyburide; Guinea Pigs; Humans; Hypoglycemic Agents; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; Prostaglandins; Rats; Rats, Wistar; Species Specificity; Tolazamide; Trachea | 1997 |
Pharmacology of human sulphonylurea receptor SUR1 and inward rectifier K(+) channel Kir6.2 combination expressed in HEK-293 cells.
Topics: ATP-Binding Cassette Transporters; Binding, Competitive; Cations; Cell Line; Deoxyglucose; Diazoxide; Dose-Response Relationship, Drug; Electric Stimulation; Electrophysiology; Fluorescence; Gene Expression; Glipizide; Glyburide; Humans; Membrane Potentials; Oligomycins; Potassium Channels; Potassium Channels, Inwardly Rectifying; Radioligand Assay; Receptors, Drug; Recombinant Fusion Proteins; RNA, Messenger; Sulfonylurea Compounds; Sulfonylurea Receptors; Tolazamide; Tolbutamide; Tritium | 2000 |
Analysis of Hypoglycemic Drugs by Liquid Chromatography-Tandem Mass Spectrometry.
Topics: Chlorpropamide; Chromatography, High Pressure Liquid; Chromatography, Liquid; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Nateglinide; Pioglitazone; Rosiglitazone; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Tolazamide; Tolbutamide | 2024 |